Healthstream (HSTM) Cash from Financing Activities (2010 - 2026)

Healthstream (HSTM) has 17 years of Cash from Financing Activities data on file, last reported at -$8.3 million in Q1 2026.

• Cash from Financing Activities for Q1 2026 came in at -$8.3 million, down 313.96% year-over-year; the trailing twelve-month figure through Mar 2026 was -$42.6 million (down 782.63% YoY), and the FY2025 annual result was -$36.3 million, down 703.08% from the prior year.
• Cash from Financing Activities eased to -$8.3 million in Q1 2026 per HSTM's latest filing, from -$7.2 million in the prior quarter.
• Over five years, Cash from Financing Activities peaked at -$20000.0 in Q3 2022 and troughed at -$20.2 million in Q1 2022.
• A 5-year average of -$5.1 million and a median of -$2.0 million in 2025 frame the typical range for Cash from Financing Activities.
• The sharpest annual moves came in 2022 and 2023: Cash from Financing Activities jumped 99.18% in 2022, then tumbled 17502.13% in 2023.
• A 5-year view of Cash from Financing Activities shows it stood at -$47000.0 in 2022, then plunged by 17502.13% to -$8.3 million in 2023, then soared by 87.51% to -$1.0 million in 2024, then sank by 601.26% to -$7.2 million in 2025, then retreated by 15.03% to -$8.3 million in 2026.
• Business Quant data shows HSTM's Cash from Financing Activities at -$8.3 million in Q1 2026, -$7.2 million in Q4 2025, and -$7.9 million in Q3 2025.